Myriad Genetics (MYGN) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -27.67% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 0.34% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -2.45% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 29.92% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 0.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -32.39% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -7.11% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 67.76% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -0.86% |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | 58.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.45% |
| Dec 31, 2025 | 71.84% |
| Sep 30, 2025 | 52.23% |
| Jun 30, 2025 | -94.85% |
| Mar 31, 2025 | -8.42% |
| Dec 31, 2024 | 13.54% |
| Sep 30, 2024 | 29.92% |
| Jun 30, 2024 | -63.70% |
| Mar 31, 2024 | -53.04% |
| Dec 31, 2023 | -32.09% |
| Sep 30, 2023 | -63.88% |
| Jun 30, 2023 | -117.73% |
| Mar 31, 2023 | -21.55% |
| Dec 31, 2022 | -154.47% |
| Sep 30, 2022 | -98.36% |
| Jun 30, 2022 | -156.89% |
| Mar 31, 2022 | -159.27% |
| Dec 31, 2021 | -268.52% |
| Sep 30, 2021 | -413.20% |
| Jun 30, 2021 | -38.26% |